SCOPUS 정보 검색 플랫폼

British Medical Journal

Volumn 327, Issue 7419, 2003, Pages 823-824

Directly observed treatment for tuberculosis

(2) Garner, Paul a Volmink, Jimmy b

a LIVERPOOL SCHOOL OF TROPICAL MEDICINE (United Kingdom)

b UNIVERSITY OF CAPE TOWN (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN; TUBERCULOSTATIC AGENT;

AFRICA; CLINICAL TRIAL; DIRECTLY OBSERVED THERAPY; DISEASE CONTROL; EDITORIAL; HEALTH CARE POLICY; HUMAN; LUNG TUBERCULOSIS; MORTALITY; PAKISTAN; POLITICS; PRIORITY JOURNAL; SOUTH AFRICA; THAILAND; UNITED STATES; WORLD HEALTH ORGANIZATION; METHODOLOGY;

ANTITUBERCULAR AGENTS; DIRECTLY OBSERVED THERAPY; HUMANS; TUBERCULOSIS, PULMONARY;

EID: 0141940192 PISSN: 09598146 EISSN: None Source Type: Journal
DOI: 10.1136/bmj.327.7419.823 Document Type: Editorial

Times cited : (29)

References (10)

1
- 0036210480
- Interventions to reduce tuberculosis mortality and transmission in low- and middle-income countries
- Borgdorff MW, Floyd K, Broekmans JF. Interventions to reduce tuberculosis mortality and transmission in low- and middle-income countries. WHO Bull 2002;80:217-27.
- (2002) WHO Bull , vol.80 , pp. 217-227
- Borgdorff, M.W.¹ Floyd, K.² Broekmans, J.F.³

2
- 0037006674
- Evolution of WHO policies for tuberculosis control, 1948-2001
- Raviglione MC, Pio A. Evolution of WHO policies for tuberculosis control, 1948-2001. Lancet 2002;359:775-80.
- (2002) Lancet , vol.359 , pp. 775-780
- Raviglione, M.C.¹ Pio, A.²

3
- 0032512283
- Prospects for worldwide tuberculosis control under the WHO DOTS strategy
- Dye C, Garnett GP, Sleeman K, Williams BG. Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Lancet 1998;352:1886-91.
- (1998) Lancet , vol.352 , pp. 1886-1891
- Dye, C.¹ Garnett, G.P.² Sleeman, K.³ Williams, B.G.⁴

4
- 0034656317
- Directly observed therapy and treatment adherence
- Volmink J, Matchaba P, Garner P. Directly observed therapy and treatment adherence. Lancet 2000;355:1345-50.
- (2000) Lancet , vol.355 , pp. 1345-1350
- Volmink, J.¹ Matchaba, P.² Garner, P.³

5
- 0003424751
- Geneva: WHO, WHO/CDS/TB/2003.313
- World Health Organization. Treatment of tuberculosis: guidelines for national programmes. Geneva: WHO, 2003 (WHO/CDS/TB/2003.313).
- (2003) Treatment of Tuberculosis: Guidelines for National Programmes

6
- 0037264425
- Directly observed therapy for treating tuberculosis
- CD003343
- Volmink J, Garner P. Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev 2003;(1):CD003343.
- (2003) Cochrane Database Syst Rev , Issue.1
- Volmink, J.¹ Garner, P.²

7
- 0038182031
- Tuberculosis control: Past 10 years and future progress
- Frieden TR, Driver CR. Tuberculosis control: past 10 years and future progress. Tuberculosis 2003;83:82-5.
- (2003) Tuberculosis , vol.83 , pp. 82-85
- Frieden, T.R.¹ Driver, C.R.²

8
- 0032565114
- Directly observed therapy for treatment completion of pulmonary tuberculosis: Consensus statement of the public health tuberculosis guidelines panel
- Chaulk CP, Kazandjian VA. Directly observed therapy for treatment completion of pulmonary tuberculosis: Consensus statement of the public health tuberculosis guidelines panel. JAMA 1998;279:943-8.
- (1998) JAMA , vol.279 , pp. 943-948
- Chaulk, C.P.¹ Kazandjian, V.A.²

9
- 0036263417
- Cost and cost-effectiveness of different DOT strategies for the treatment of tuberculosis in Pakistan
- Khan MA, Walley JD, Witter SN, Imran A, Safdar N. Cost and cost-effectiveness of different DOT strategies for the treatment of tuberculosis in Pakistan. Health Policy Plan 2002;17:178-86.
- (2002) Health Policy Plan , vol.17 , pp. 178-186
- Khan, M.A.¹ Walley, J.D.² Witter, S.N.³ Imran, A.⁴ Safdar, N.⁵

10
- 0142017716
- Tuberculosis
- London: BMJ Publishing Group
- Garner P, Holmes A. Tuberculosis. In: Clinical Evidence. Issue 9. London: BMJ Publishing Group. 2003:901-10.
- (2003) Clinical Evidence , Issue.9 , pp. 901-910
- Garner, P.¹ Holmes, A.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.